FDA Drug Recalls

Recalls / Class II

Class IID-0677-2022

Product

Desoximetasone Ointment USP, 0.05%, packaged in a) 100 grams tubes, NDC 52565-045-99; b) 60 grams tubes, NDC 52565-045-60, Rx only, Manufactured by: Teligent Pharma, Inc., Buena, New Jersey 08310.

Affected lot / code info
Batch: a) 15196, Exp. 2/28/2022; 16605, Exp. 3/31/2023; b)15190, Exp. 2/28/2022; 16660, Exp. 4/30/2023; 17037, Exp. 6/30/2023; 17163, Exp. 8/31/2023

Why it was recalled

cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

Recalling firm

Firm
Teligent Pharma, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
105 Lincoln Avenue, N/A, Buena, New Jersey 08310

Distribution

Quantity
54,897 tubes
Distribution pattern
Nationwide in the USA and Puerto Rico

Timeline

Recall initiated
2022-03-15
FDA classified
2022-03-21
Posted by FDA
2022-03-30
Terminated
2024-06-17
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0677-2022. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.